On Thursday, Cellectar Biosciences Inc (NASDAQ: CLRB) was 1.48% up from the session before settling in for the closing price of $4.73. A 52-week range for CLRB has been $4.36 – $94.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 40.27% over the last five years. When this article was written, the company’s average yearly earnings per share was at 58.04%. With a float of $1.75 million, this company’s outstanding shares have now reached $1.81 million.
The firm has a total of 11 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cellectar Biosciences Inc (CLRB) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cellectar Biosciences Inc stocks. The insider ownership of Cellectar Biosciences Inc is 1.67%, while institutional ownership is 9.68%. The most recent insider transaction that took place on Jul 02 ’25, was worth 49,900. In this transaction Chief Executive Officer of this company bought 10,000 shares at a rate of $4.99, taking the stock ownership to the 11,638 shares. Before that another transaction happened on Jul 02 ’25, when Company’s Chief Operating Officer bought 10,000 for $4.99, making the entire transaction worth $49,900. This insider now owns 12,768 shares in total.
Cellectar Biosciences Inc (CLRB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 58.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.04% during the next five years compared to 40.27% growth over the previous five years of trading.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
You can see what Cellectar Biosciences Inc (CLRB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -22.45, a number that is poised to hit -3.72 in the next quarter and is forecasted to reach -13.08 in one year’s time.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
Analysing the last 5-days average volume posted by the [Cellectar Biosciences Inc, CLRB], we can find that recorded value of 0.31 million was better than the volume posted last year of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 6.61%.
During the past 100 days, Cellectar Biosciences Inc’s (CLRB) raw stochastic average was set at 2.71%, which indicates a significant decrease from 4.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 189.24% in the past 14 days, which was higher than the 141.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.62, while its 200-day Moving Average is $23.66. Now, the first resistance to watch is $5.11. This is followed by the second major resistance level at $5.42. The third major resistance level sits at $5.67. If the price goes on to break the first support level at $4.55, it is likely to go to the next support level at $4.30. Now, if the price goes above the second support level, the third support stands at $3.99.
Cellectar Biosciences Inc (NASDAQ: CLRB) Key Stats
There are 1,810K outstanding shares of the company, which has a market capitalization of 8.70 million. As of now, sales total 0 K while income totals -44,580 K. Its latest quarter income was 0 K while its last quarter net income were -6,600 K.
